|
 |
BexxarThis page contains recent news articles, when available, and an overview of Bexxar but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Two other drugs, Bexxar and Zevalin, were also developed on the same principle of targeting that B-cell receptor molecule. Back to the Dutch study. ... North County Times (blog) Targeting B-Cell Surface Proteins to Fight Cancer - Nov 6, 2009 Current medications that target CD20 include rituximab (Rituxan or MabThera), Ibritumomab tiuxetan (Zevalin) and tositumomab (Bexxar). ... Mesothelioma Web Data Support Earlier Bexxar Use - May 14, 2005 By TSC Staff. GlaxoSmithKline (GSK - commentary - Cramer's Take) said the outcomes associated with the Bexxar therapeutic regimen in non-Hodgkin's lymphoma ... TheStreet.com - TheStreet.com (subscription) Market Forces Cited in Lymphoma Drugs' Disuse - Jul 14, 2007 All three recovered after a single dose of Bexxar or Zevalin, both federally approved ... But fewer than 2000 patients received Bexxar or Zevalin last year, ... New York Times Study: Lymphoma Treatment Shows Promise - Feb 2, 2005 Bexxar is only approved for use when other therapies, ... Bexxar treatment starts with a test dose followed by a full dose a week later instead of over ... FOXNews Medicare Cuts Payout on 2 Cancer Drugs - Dec 7, 2007 GlaxoSmithKline, which markets Bexxar, says it is priced at almost $30000 a ... Because Bexxar and Zevalin contain radioactive material, the drugs must be ... New York Times Glaxo Continues Its Dealmaking - Dec 19, 2006 If that happens, Genmab also will have the option to co-promote a pair of GlaxoSmithKline cancer drugs, Bexxar for non-Hodgkins lymphoma and Arranon for ... TheStreet.com - TheStreet.com (subscription) 'A smart guided missile' to cancer cells ; Radiation therapy remission... - Feb 3, 2005 In the report in today's New England Journal of Medicine, Bexxar shrank tumors in 95% ... Therapy with Bexxar, now sold by GlaxoSmithKline, lasts one week, ... Pay-Per-View - USA TODAY - ProQuest Archiver New Lymphoma Treatment Promising - Jun 4, 2007 Bexxar combines the antibody (tositumomab) with radioactive iodine and is ... “The big advantage is that Bexxar is given in one week, with very little ... WebMD Bexxar - Tag Story Index - USATODAY.com - Apr 30, 2007 By Lauran Neergaard, AP Medical Writer. Only a fraction of patients with hard-to-treat lymphoma ever try two breakthrough "smart-bomb" drugs that bring ... USA Today Non-Hodgkin's Lymphoma on the Rise, Along With Prospects for a Cure - Mar 4, 2008 More recently, two variations on Rituxan — Bexxar and Zevalin — have joined the fight. Both are monoclonal antibodies armed with small radioactive particles ... New York Times Lymphoma, Non-Hodgkin's - Overview - NY Times Health - Apr 4, 2008 More recently, two variations on Rituxan — Bexxar and Zevalin — have joined the fight. Both are monoclonal antibodies armed with small radioactive particles ... New York Times … Announces Expanded Indication for BEXXAR in Non-Hodgkin's … - Jan 3, 2005 PHILADELPHIA, Jan. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved a supplemental ... RedOrbit New Medicare Rules Bar Cancer Drugs for Patients - Dec 10, 2007 Bexxar is a one-shot deal with no or very few side effects. ... Currently, only two drugs — Bexxar and Zevalin — fall under this class of therapy. ... ABC News Glaxo surges after picking up vaccine booster firm - May 4, 2005 GSK and Corixa previously worked together on the cancer product Bexxar but the British company has acquired full rights for Bexxar. ... Telegraph.co.uk How DC Is Nixing a Cancer Cure | Newsweek Voices - Jonathan Alter | … - Nov 22, 2007 You would think all of this would mean booming sales for Bexxar and Zevalin and ... But generally speaking, Bexxar and Zevalin are being dramatically ... Newsweek Encouraging news about a novel way to fight cancer - Feb 3, 2005 It finds that injecting a type of liquid radiation, called Bexxar, into patients ... When Bexxar was used to combat non-Hodgkin's lymphoma, 59 percent of ... ABC News Medicare Balks at Paying for Lymphoma Drugs - Dec 12, 2007 Zevalin and a similar drug called Bexxar are approved for use when non-Hodgkin's lymphoma comes back ... But Bexxar and Zevalin have two major problems. ... NPR Article: RADIATION TREATMENT FOR LYMPHOMA SHOWS PROMISE.( … - Feb 3, 2005 ODAC Panel Agrees That BEXXAR Studies Show Clinical Benefit in Chemotherapy ... the ... Article: Bexxar following chemotherapy produced high rate of ... ... Pay-Per-View - Cincinnati Post - HighBeam Research Promising Treatment for Some NHL Patients - Sep 5, 2006 According to the drug's manufacturer, GlaxoSmithKline, BEXXAR is not ... Information about BEXXAR from its manufacturor, GlaxoSmithKline, is available here. Cancerpage.com Biogen Radiation Drug, a Single Shot, Halts Lymphoma - Dec 9, 2007 Zevalin and GlaxoSmithKline Plc's Bexxar are the only two approved ... Zevalin typically costs hospitals $22000 to $24000 while Bexxar costs $28000 to ... Bloomberg GlaxoSmithKline to buy Corixa - Apr 30, 2005 The cancer drug that it nurtured for years, Bexxar, flopped in its first year on the ... It expected to sell about $20 million of Bexxar in its first year. ... Seattle Times Ethicon will use Microvision imaging technology - Jan 4, 2005 The Food and Drug Administration (FDA) has approved Bexxar for expanded use in ... GlaxoSmithKline said 47 percent of the patients responded to Bexxar ... Seattle Times Former Dendreon CFO Burris joins Trubion - Jan 26, 2006 At that company, she was part of a team that won federal approval of Bexxar, a treatment for non-Hodgkin's lymphoma. She and others helped raise more than ... nwsource.com Award-Winning Journalist Jamie Reno Assures Lymphoma Patients That ' … - Jul 29, 2008 BEXXAR, which was an experimental therapy at the time, has since been approved by the FDA for patients with non-Hodgkin's lymphoma whose disease has ... RedOrbit New treatment rivals chemotherapy for lymphoma, UM study finds - Feb 8, 2005 The newly published research involves Bexxar as a first-line treatment for this ... Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, ... Medical News Today - Medical News Today (press release) Is the market alone responsible for Bexxar and Zevalin being underus ... - Jul 16, 2007 The recent article suggests that Bexxar and Zevalin are extremely effective drugs with few side effects that are infrequently prescribed because of ... Gerson Lehrman Group Glaxo buys Seattle biotech firm for $300M - May 2, 2005 ...not only in proprietary vaccine antigen discovery and development, but as the leading customer for our adjuvants and as a co-developer of Bexxar. ... Bizjournals.com … : New Analysis Shows Earlier Use of BEXXAR May Improve Treatment … - May 14, 2005 New Analysis Shows Earlier Use of BEXXAR May Improve Treatment Outcomes in Non-Hodgkin's Lymphoma Patients. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: 8-YEAR LONG-TERM DATA DEMONSTRATE … - Jun 4, 2007 ..."For years we have known that radioimmunotherapy, such as BEXXAR, ... The data from this frontline study suggest that BEXXAR may also have activity when ... Pay-Per-View - PR Newswire - HighBeam Research Seattle high-tech layoff tracker | Seattle Post-Intelligencer - Jul 19, 2005 In December 2004, GlaxoSmithKline purchased Bexxar, then Corixa's lead drug. That purchase and layoffs in Seattle and South San Francisco back then marked ... Seattle Post-Intelligencer - Seattle Post Intelligencer "Smart bombs" for lymphoma underused - May 1, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody target but with different radioactive drugs attached to ... komotv.com MDS Nordion Supports GlaxoSmithKline Inc. in Providing Innovative … - Nov 24, 2005 Made by GSK, Bexxar is the latest in a new generation of patient-tailored cancer treatments ... Recently approved in Canada, and now available, Bexxar is a ... biotech-intelligence.com Gsk To Balance Bexxar Expanded Indication Against Lower Response … - Jan 10, 2005 GlaxoSmithKline may encounter promotional challenges with the second-line indication Bexxar has gained, due to oncologic's response rate being lower in the ... Cancer Consultants January 1 Looms Large for Lymphoma Patients. - Nov 27, 2007 The drugs in jeopardy are two radioimmunotherapies -- Bexxar(R) and Zevalin(R) -- which are both critically important treatment options for patients with ... Free with registration - PR Newswire - AccessMyLibrary.com New Treatment Rivals Chemotherapy For Lymphoma, Study Finds - Feb 9, 2005 The newly published research involves Bexxar as a first-line treatment for this ... Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, ... Biology News Net - Biology News Net (press release) … Lymphoma; Company announces expanded indication for BEXXAR in … - Feb 4, 2005 The BEXXAR Therapeutic Regimen is now indicated for the treatment of patients with CD20 antigen-expressing relapsed or refractory, low-grade, follicular, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Restructuring; BEXXAR rights transferred to GlaxoSmithKline - Jan 11, 2005 2005 JAN 11 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA), a developer of immunotherapeutics, announced that it has reached an agreement with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Lymphoma Drug Effective Over Long Term - May 30, 2007 ..."For years we have known radioimmunotherapy such as Bexxar is one of the most effective ... These data show Bexxar is particularly effective when used as a ... newswise.com Article: Study: treatment that gets radiation right to cancer cells... - Feb 3, 2005 Bexxar is currently only approved for use when other therapies, ... Bexxar treatment starts with a test dose followed by a full dose a week later instead of ... Pay-Per-View - AP Worldstream - HighBeam Research Center News - 10/19/06 - Press Lab increases follicular lymphoma … - Oct 19, 2006 When combined with the relative newcomer Bexxar, the trade name for a ... "The study with CHOP followed by Bexxar has had the best results of any study in ... Hutchinson Center A Life of Science Q4 2004 CORIXA CORP Earnings Conference Call - Final. - Mar 14, 2005 In December we announced the sale and transfer of BEXXAR worldwide developing ... While we continue to believe in the promise of BEXXAR and its benefit for ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Lymphoma; New treatment rivals chemotherapy for lymphoma - Feb 21, 2005 The newly published research involves Bexxar as a first-line treatment for this ... Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones FDA Approvals: Bexxar, Vfend, and First-Time Generics - Jan 13, 2005 Jan. 13, 2005 — The US Food and Drug Administration (FDA) has approved an expanded indication for tositumomab therapy, allowing its use in a broader ... Medscape Lymphoma; New treatment rivals chemotherapy for lymphoma - Feb 26, 2005 The newly published research involves Bexxar as a first-line treatment for this ... Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Tositumomab Brings New Hope for Refractory Non-Hodgkin's Lymphoma - Sep 10, 2005 Health Canada approved Bexxar(TM) (tositumomab and iodine I 131 tositumomab) ... "Bexxar represents an important new direction in cancer therapy," says Dr. ... RxPG NEWS Uncle Sam, MD - Jun 18, 2007 Almost 13 years after the drug Bexxar was first used in cancer patients, the Food and Drug ... Bexxar represents a leading edge of cancer innovation, ... Subscription - Wall Street Journal Online - Dow Jones & Company Article: Study: Lymphoma Treatment Shows Promise - AP Online | … - Feb 3, 2005 ODAC Panel Agrees That BEXXAR Studies Show Clinical Benefit in Chemotherapy ... the ... Article: Bexxar following chemotherapy produced high rate of ... ... Pay-Per-View - AP Online - HighBeam Research Article: Study: Lymphoma Treatment Shows Promise - AP Online | … - Feb 2, 2005 ODAC Panel Agrees That BEXXAR Studies Show Clinical Benefit in Chemotherapy ... the ... Article: Bexxar following chemotherapy produced high rate of ... ... Pay-Per-View - AP Online - HighBeam Research Study: Lymphoma Treatment Shows Promise | Article from AP Online | … - Feb 4, 2005 Bexxar is only approved for use when other therapies, ... Bexxar treatment starts with a test dose followed by a full dose a week later instead of over ... Pay-Per-View - AP Online - HighBeam Research US Food, Drug Watchdog Gives Glaxo Boost - Jan 5, 2005 Glaxo is in the process of buying total rights to Bexxar from Corixa Corp, which developed the drug. Separately, US group Merck was under pressure after a ... RedOrbit Lymphoma Drug Effective Over Long Term, UM Study Finds - Jun 9, 2007 ..."For years we have known radioimmunotherapy such as Bexxar is one of the most effective ... These data show Bexxar is particularly effective when used as a ... Medical News Today - Medical News Today (press release) Corixa licenses antibody target to Genentech for $1.6M - Jan 13, 2005 San Francisco facilities, and will sell the rights and development responsibilities of its most advanced cancer drug, Bexxar, to GlaxoSmithKline PLC. ... Puget Sound Business Journal Federal Register 2006 - 71 FR 34285 William Stein III, MD; Receipt of... - Jun 14, 2006 Bexxar has been approved by the FDA for intravenous treatment of ... The petitioner also states that the I-131 present in Bexxar is firmly attached to the ... Pay-Per-View - Federal Register 2006 - Loislaw Dendreon Announces Organizational Changes. - Nov 11, 2005 ..."During her 10 years at Corixa, Michelle played a central role in the successful development and approval of Bexxar(R), an antibody drug for the treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: MDS Nordion Supports GlaxoSmithKline Inc. in Providing... - Nov 24, 2005 Bexxar(TM) therapy now available to Canadians with non-Hodgkin's lymphoma ... Made by GSK, Bexxar is the latest in a new generation of patient-tailored ... Pay-Per-View - PR Newswire - HighBeam Research Lymphoma Drug Is Effective Over Long Term - Jun 7, 2007 ..."For years we have known radioimmunotherapy such as Bexxar is one of the most effective ... These data show Bexxar is particularly effective when used as a ... emaxhealth.com The Insider: Bill Gates for vice president? Uh, no... - Jul 6, 2008 There are two radioimmunotherapies on the market: Bexxar and Zevalin. ... Zevalin is sold by Cell Therapeutics, while Bexxar was developed by Seattle's ... Seattle Post-Intelligencer - Seattle Post Intelligencer New treatment rivals chemotherapy for lymphoma - Mar 2, 2005 The newly published research involves Bexxar as a first-line treatment for this ... Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, ... innovations report - Innovations-Report Lymphoma drug failure frustrates experts - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody target but with different radioactive drugs attached to ... USA Today New lymphoma treatment has 75% success rate in trial | Article from … - Feb 3, 2005 Bexxar is approved for use only when other therapies, ... Bexxar treatment starts with a test dose followed by a full dose a week later instead of over ... Pay-Per-View - Deseret News - HighBeam Research Lymphoma Drug Effective Over Long Term: Presented at ASCO - Jun 12, 2007 ..."For years we have known radioimmunotherapy such as Bexxar is one of the most effective ... These data show Bexxar is particularly effective when used as a ... DG News New help comming from drugs - Sep 25, 2006 Patients were treated with CHOP followed by Bexxar. The study showed that overall anticancer response was 90 percent when receiving Bexxar after CHOP regime ... TopCancerNews.com Daily Cancer News - Aug 13, 2007 Bexxar is a radioimmunotherapeutic agent that was approved by the FDA in 2003 for the ... Bexxar is an antibody with radioactive iodine 131 attached. ... Cancer Consultants EFFECTIVE LYMPHOMA DRUGS NOT OFTEN USED - Jul 16, 2007 All three recovered after a single dose of Bexxar or Zevalin, both federally approved ... But fewer than 2000 patients received Bexxar or Zevalin last year, ... $2.95 - Lexington Herald Leader - NewsBank å…¨ç?ƒé¦–个肺癌放射å…?ç–«è?¯ç‰©æˆ?功上市-金色航城论å?›-æ?œç‹?焦点网上海站 - Feb 2, 2007 ...ç›®å‰?，全ç?ƒä»…有两个放射å…?疫治疗è?¯ç‰©ï¼Œ90Y-ibritumomab(Zevalin)å’Œ131I-tositumomab(Bexxar) ç»?美国FDA批准用于淋巴瘤的治疗。Zevalinå’ŒBexxar在欧美已ç»?开始广泛应用， ... 焦点房地产 Press Release: MDS Nordion to Supply Cardiac Imaging Pharmaceutical … - Feb 16, 2006 131), used in Bexxar(TM) therapy. Made by GSK ... hours a day. BEXXAR(TM) is used under license ... External Communications, MDS Nordion, Tel: (613) 592 . ... Pay-Per-View - PR Newswire - HighBeam Research Bill stalls, along with Zevalin reimbursement - Jul 3, 2008 There are two radioimmunotherapies on the market -- Bexxar and Zevalin. ... Zevalin is sold by Cell Therapeutics, while Bexxar was developed by Seattle's ... nwsource.com Federal Register 2007 - 72 FR 60285 William Stein, III, MD; Denial of... - Oct 24, 2007 ...(2) Add a separate requirement for Quadramet, Bexxar, and Zevalin similar to the ... The petitioner noted that all administrations of Quadramet, Bexxar, ... Pay-Per-View - Federal Register 2007 - Loislaw Bexxar, un nuevo régimen terapéutico efectivo para el linfoma... - Apr 2, 2005 Un régimen terapéutico llamado Bexxar, que combina el anticuerpo anti-CD20 tositumomab y yodo radiactivo, induce remisiones prolongadas en pacientes con ... doyma.es Trubion's anti-CD20 SMIP platform: 'best thing ever'?(Potential $840M... - Jan 9, 2006 Bexxar (tositumomab, iodine-131), the radiolabeled monoclonal antibody for CD20-positive ... Weintraub called Zevalin and Bexxar "commercial failures. ... Free with registration - Bioworld Financial Watch - AccessMyLibrary.com Radioimmunotherapy is an option for some lymphoma patients - Jul 25, 2007 The New York Times profiles the low usage of two drugs, Bexxar and Zevalin, ... Unfortunately, once Bexxar or Zevalin are finally used, often after many ... TopCancerNews.com 'Smart-bomb' drugs for lymphoma remain underused - May 8, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody target but with different radioactive drugs attached to ... Sauk Valley Newspapers Smart bombs for lymphoma underused - May 4, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody target but with different radioactive drugs attached to ... Napa Valley Register Lymphoma Drug Failure Frustrates Experts | Article from AP Online | … - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody but with radioactive drugs attached to give lymphoma a ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Smart Bombs for Lymphoma Not Used Enough | Article from AP Online | … - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody but with radioactive drugs attached to give lymphoma a ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Lymphoma Drug Failure Frustrates Experts | Article from AP Online | … - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody target but with different radioactive drugs attached to ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Smart Bombs for Lymphoma Not Used Enough | Article from AP Online | … - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody but with radioactive drugs attached to give lymphoma a ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Lymphoma Drug Failure Frustrates Experts - AP Online | … - Apr 30, 2007 When that happens, Zevalin and Bexxar are government-approved options. They use the same antibody but with radioactive drugs attached to give lymphoma a ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Corixa shareholders approve GlaxoSmithKline merger - AP … - Jul 12, 2005 The resolution means Corixa and its Bexxar partner, GlaxoSmithKline ... ... Article: CORIXA SELLS BEXXAR TO GSK, CUTS STAFF BY 160 EMPLOYEES. ... Pay-Per-View - AP Worldstream - HighBeam Research Article: Free shielding kit.(EMC PRODUCTS) - EE-Evaluation Engineering... - Aug 1, 2006 Biodex Medical Systems, Inc. now offers shielding products for BEXXAR. The Dose Preparation Sytem is used to prepare a BEXXAR dose. ... Pay-Per-View - EE-Evaluation Engineering - HighBeam Research Briefing - Feb 3, 2005 Dr. Mark S. Kaminski developed the treatment, Bexxar, with a University of Michigan colleague. ... Bexxar is approved for use when other therapies fail. ... Pay-Per-View - Newsday - ProQuest Archiver Changing Dynamics in the European Non-Hodgkin's Lymphoma Market - Mar 17, 2008 Another promising radio-immuno therapy is Bexxar from GSK. It is marketed in Europe by Amersham Health which has been recently accquired by GE Healthcare. ... OBBeC.com How DC Is Nixing a Cancer Cure | Newsweek Voices - Jonathan Alter | … - Nov 13, 2007 Bexxar produced at least some response in 97 percent of patients in one study. Particularly for older patients who cannot handle a stem cell transplant, ... Newsweek Glaxo signs US deal to boost vaccine profits - May 1, 2005 But the modest sales from Bexxar forced Corixa to hand over worldwide rights and manufacturing to Glaxo in December. This was interpreted as ending Corixa's ... Times Online New discoveries in treatment for patients with non-Hodgkin's lymphoma - Jun 20, 2005 In "An Update of Complete Response Durability Following Tositumomab and Iodine I-131 Tositumomab (the Bexxar Therapeutic Regimen) in a Pivotal Study of ... News-Medical.net Press Release: Indevus Receives Approvable Letter from FDA for … - Jun 30, 2008 Review Letter Following FDA Evaluation of Bexxar ... Corixa has modified its operating plan as a result of Bexxar ... ... Pay-Per-View - PR Newswire - HighBeam Research Insider tales from the biotech front - Sep 8, 2006 Though Corixa brought an effective cancer drug, Bexxar, to market, it was never able to gain market share over competitor Rituxan despite superior clinical ... sptimes.com Anger over FDA 'brake on Glaxo' ; HEALTH | Article from Evening … - Jun 17, 2008 Bexxar was jointly developed by Glaxo and Corixa and approved by the US Food and Drug Administration (FDA) in 2003 as a treatment for a cancer . ... Pay-Per-View - Evening Standard - London - HighBeam Research Article: Shielding products.(LITERATURE MARKETPLACE) - EE- … - Apr 1, 2007 Biodex Medical Systems, Inc. now offers shielding products for BEXXAR. The Dose Preparation Sytem is used to prepare a BEXXAR dose. ... Pay-Per-View - EE-Evaluation Engineering - HighBeam Research Article: Low-compression gasket.(EMC PRODUCT SHOWCASE) - EE- … - Mar 1, 2007 Biodex Medical Systems, Inc. now offers shielding products for BEXXAR. The Dose Preparation Sytem is used to prepare a BEXXAR dose. ... Pay-Per-View - EE-Evaluation Engineering - HighBeam Research Article: Shielding Products.(LITERATURE MARKETPLACE) - EE- … - Nov 1, 2007 Biodex Medical Systems, Inc. now offers shielding products for BEXXAR. The Dose Preparation Sytem is used to prepare a BEXXAR dose. ... Pay-Per-View - EE-Evaluation Engineering - HighBeam Research Medicare reimbursement change criticized. - Dec 17, 2007 A course of Bexxar or Zevalin can cost $30000 and $50000, respectively, the manufacturers say. ... Dr Kaminski was one of the Bexxar discovery team. ... $4.95 - Pharma Marketletter - ECNext State lawmaker goes radioactive in bid to kill cancer - Jul 28, 2007 Different than standard chemo or radiation, the Bexxar treatment uses synthetic antibodies that are engineered, like microscopic keys, to slot only into ... Seattle Post-Intelligencer - Seattle Post Intelligencer Outlook Brighter for Patients With Follicular Lymphoma - Mar 7, 2006 The authors pointed out that it wasn't clear if Bexxar worked better than Rituxan. They are proposing a clinical trial to study this. ... ACS News Center Article: Review status - New Straits Times | HighBeam Research - FREE... - Jun 21, 2005 SmithKline Beecham announce priority review status for Bexxar (C)1994-2000 M2 ... tositumomab) has been assigned priority review status by the U.S. Food and ... Pay-Per-View - New Straits Times - HighBeam Research Article: Seeking solutions to child poverty; Medical College symposium... - Oct 7, 2007 BEXXAR gives doctors a new tool and patients new hope for fighting this deadly ... BEXXAR therapy was developed ... MD, Clinical Director of the Center for ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Article: Glaxo takes on two in race for Pfizer's consumer arm. - The ... - Jun 7, 2006 Byline: BILL CONDIE SEATTLE-based biotech firm Corixa is selling worldwide rights to its Bexxar cancer treatment to GlaxoSmithKline Corixa, ... Pay-Per-View - Evening Standard - HighBeam Research Non-Hodgkin's lymphoma - Mar 28, 2008 Two radioimmunotherapy drugs — ibritumomab (Zevalin) and tositumomab (Bexxar) — are currently FDA-approved. Radioimmunotherapy uses monoclonal antibodies ... CNN International Article: Glaxo takes on two in race for Pfizer's consumer arm. - The ... - Jun 7, 2006 Byline: BILL CONDIE SEATTLE-based biotech firm Corixa is selling worldwide rights to its Bexxar cancer treatment to GlaxoSmithKline Corixa, ... Pay-Per-View - Evening Standard - HighBeam Research Se utilizan poco las "bombas inteligentes" contra linfomas - Apr 30, 2007 Sólo dos fármacos para combatir el cáncer linfático se venden bajo las marcas Zevalin y Bexxar. Sin embargo, se están efectuando en sus primeras etapas más ... AZ Central.com Tositumomab and ^Sup 131^I Therapy in Non-Hodgkin's Lymphoma - Jan 26, 2005 This review focuses on the clinical experience with the Bexxar therapeutic regimen at radiation doses designed not to require stem cell support ... RedOrbit |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |